Skip to main content
Log in

Behavioral screen for antidepressants: The effects of drugs and electroconvulsive shock on performance under a differential-reinforcement-of-low-rate schedule

  • Original Investigations
  • Published:
Psychopharmacology Aims and scope Submit manuscript

Abstract

Those antidepressant drugs that are, in wide clinical use decrease response rate and increase reinforcement rate when administered to rats performing on a differential-reinforcement-of-low-rate 72-s (DRL 72-s) schedule. Drugs that are not antidepressants do not have this effect. In this experiment, the following were examined for their effects on a DRL 72-s schedule: tranzodone, zimelidine, fluoxetine, and bupropion (atypical antidepressants); electroconvulsive shock (ECS, which is an effective treatment for depression); and haloperidol and clozapine (antipsychotic drugs). Trazodone (3.12–25.00 mg/kg), fluoxetine (10–20 mg/kg), and ECS decreased response rate and increased reinforcement rate. Zimelidine (20 mg/kg) increased reinforcement rate and nonsignificantly decreased response rate. At doses between 2.5 and 40 mg/kg, bupropion had no effect on reinforcement rate or response rate, but at 60 mg/kg response rate was increased and reinforcement rate was nonsignificantly decreased. At the higher dose, the effects of bupropion resemble those of a psychomotor stimulant. Haloperidol (0.04 mg/kg) and clozapine (2.5–10.0 mg/kg) decreased response rate and reinforcement rate. These results, suggest that the DRL 72-s schedule may be useful for testing the antidepressant potential of new drugs.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  • Abrams R (1975) What's new in convulsive therapy? In: Arieti S, Chrozanowski G (eds) New dimension in psychiatry. Wiley, New York, pp 86–97

    Google Scholar 

  • Agnoli A, Piccione M, Casacchia M, Fazio C (1974) Trazodone versus desipramine: A double-blind study on the rapidity of the antidepressant effect. In: Ban TA, Silverstrini B (eds) Modern problems of pharmaco-psychiatry, vol 9. Karger, Basel, pp 190–198

    Google Scholar 

  • Ando K (1975) Profile of drug effects on temporally spaced responding in rats. Pharmacol Biochem Behav 3:833–841

    Google Scholar 

  • Cassano GB, Conti L, Dell'Osso L, Massimetti G (1982) Four new antidepressants (trazodone, mianserin, nomifensine, caroxazone): Results of controlled trials. In: Costa E, Racagni G (eds) Typical and Atypical antidepressants: Clinical practice. Raven, New York, pp 125–140

    Google Scholar 

  • Chouinard G (1983) Bupropion and amitriptyline in the treatment of depressed patients. J Clin Psychiatry 44:121–129

    Google Scholar 

  • Feighner JP (1980) Trazodone, a triazopyridine derivative in primary depressive disorder. J Clin Psychiatry 41:250–255

    Google Scholar 

  • Ford RD, Balster RL (1976) Schedule-controlled behavior in the morphine-dependent rat. Pharmacol Biochem Behav 4:569–573

    Google Scholar 

  • Griffith JD, Carranza J Griffith C, Miller LL (1983) Bupropion: Clinical assay for amphetamine-like abuse potential. J Clin Psychiatry. 44:206–208

    Google Scholar 

  • Harto-Truax N, Stern WC, Miller LL, Sato TL, Cato AE (1983) Effects of bupropion on body weight. J Clin Psychiatry 44:183–186

    Google Scholar 

  • Hollister LE (1978) Psychiatric disorders. In: Melmon KL, Morelli HF (eds) Clinical pharmacology: Basic principles in therapeutics. MacMillan, New York, pp 842–873

    Google Scholar 

  • Howard JL, Jones CN, McBennett ST (1978) Discriminative stimulus properties of antidepressants. In: Colpaert FC, Rosencrans JA (eds) Stimulus properties of drugs: Ten years of progress. Elsevier/North-Holland, Amsterdam, pp 157–166

    Google Scholar 

  • Howard JL, Soroko, FE, Cooper BR (1981) Empirical behavioral models of depression with emphasis on tetrabenazine antagonism. In: Enna SJ, Malick JB, Richelson E (eds) Antidepressants: Neurochemical, behavioral, and clinical perspectives. Raven, New York, pp 107–120

    Google Scholar 

  • Klerman GL, Cole JO (1965) Clinical pharmacology, of imipramine and related antidepressant compounds. Pharmacol Rev 17:101–141

    Google Scholar 

  • Laties VG, Weiss B (1962) Effects of alcohol on timing behavior. J Comp Physiol Psychol 55:85–91

    Google Scholar 

  • Longo VG, Scotti de Carolis A (1974) Pharmacological features of trazodone. In: Ban TA, Silvestrini B (eds) Modern problems of pharmacopsychiatry, vol. 9. Karger, Basel, pp 95–109

    Google Scholar 

  • Malick JB (1981) Yohimbine potentiation as predictor of antidepressant action. In: Enna SJ, Malick JB, Richelson E (eds) Antidepressants: Neurochemical, behavioral and cinical perspectives. Raven, New York, pp 141–155

    Google Scholar 

  • McGuire PS (1980a) The effects of tricyclic antidepressants on performance under a differential-reinforcement-of-low-rate schedule in rats. J Pharmacol Exp Ther 214:635–641

    Google Scholar 

  • McGuire PS, Seiden LS (1980b) Differential effects of imipramine in rats as a function, of DRL schedule value. Pharmacol Biochem Behav 13:691–694

    Google Scholar 

  • Mendels J, Amin MM, Chouinard G, Cooper AJ, Miles JE, Remick RA, Saxena B, Secunda SK, Singh AN (1983) A comparative study of bupropion and amitriptyline in depressed outpatients. J Clin Psychiatry 44:118–120

    Google Scholar 

  • Montgomery SA, Montgomery DB, McAuley R, Rani SJ, Roy D (1982) Profile of antidepressant action of zimelidine and norzimelidine compared with amitriptyline. In: Costa E, Racagni G (eds) Typical and atypical antidepressants: Clinical practice. Raven, New York, pp 35–42

    Google Scholar 

  • Nomura S, Shimizu J, Kinjo M, Kametau H, Nakazawa T (1982) A new behavioral test for antidepressant drugs. Eur. J Pharmacol 83:171–175

    Google Scholar 

  • O'Donnell JM, Seiden LS (1982) Effects of monoamine oxidase inhibitors on performance during differential reinforcement of low response rate. Psychopharmacology 78:214–218

    Google Scholar 

  • O'Donnell JM, Seiden LS (1983) Differential-reinforcement-of-low-rate 72-sec schedule: Selective effects of antidepressant drugs. J Pharmacol Exp Ther 224:80–88

    Google Scholar 

  • Pearl RG, Seiden LS (1976) The existence of tolerance to and cross-tolerance between d-amphetamine and methylphenidate for their effects on milk consumption and on differential-reinforcement-of-low-rate performance in the rat. J Pharmacol Exp Ther 198:635–647

    Google Scholar 

  • Pollard GT, Howard JL (1983) Effects of imipramine, bupropion, chlorpromazine, clozapine, diphenhydramine and prefeeding on rats responding under a differential-reinforcement-of-low-rate 72-s schedule (DRL 72). Soc Neurosci. Abstr, 36.2

  • Porsolt RD (1981) Behavioral despair. In: Enna SJ, Malick JB, Richelson E (eds) Antidepressants: Neurochemical, behavioral and clinical perspectives. Raven, New York, pp 121–139

    Google Scholar 

  • Porsolt RD, Anton G, Blavet N, Jalffe M (1977) Behavioral despair in rats: A new model sensitive to antidepressant treatments. Eur J Pharmacol 47:379–391

    Google Scholar 

  • Quitkin F, Rifkin A, Klein DF (1979) Monoamine oxidase inhibitors: A review of antidepressant effectiveness. Arch. Gen Psychiatry 36:749–760

    Google Scholar 

  • Sanger DJ, Key M, Blackman DE (1974) Differential effects of chlordiazepoxide and d-amphetamine on responding maintained by a DRL schedule of reinforcement. Psychopharmacology 38:159–171

    Google Scholar 

  • Shopsin B, Cassano GB, Conti L (1981) An overview of new “second generation” antidepressant compounds: Research and treatment implications. In: Enna SJ, Malick JB, Richelson E (eds) Antidepressants: Neurochemical, behavioral and clinical perspectives. Raven, New York, pp 219–251

    Google Scholar 

  • Silvestrini B, Lisciani R (1973) Pharmacology of trazodone. Curr Ther Res 15:749–754

    Google Scholar 

  • Snapper AG, Kadden RM (1973) Time-sharing on a small computer based on a behavioral notation system. In: Weiss B (ed) Digital computers in the behavioral laboratory. Appleton-Century-Crofts, New York, pp 41–97

    Google Scholar 

  • Stern WC, Harto-Truax N, Rogers J, Miller L (1982) Clinical profile of the novel antidepressant bupropion. In: Costa E, Racagni G (eds) Typical and atypical, antidepressants: Clinical practice. Raven, New York, pp 21–34

    Google Scholar 

  • Sulser F (1982) Antidepressant drug research: Its impact on neurobiology and psychobiology. In: Costa E, Racagni G (eds) Typical and atypical antidepressants: molecular mechanisms. Raven, New York, pp 1–20

    Google Scholar 

  • Turski L, Czuazwor SJ, Turski W, Kleinok Z (1981) Effects of trazodone, mianserin, iprinodole and zimelidine on wet dog shakes produced by carbachol in rats. J Pharm Pharmacol 33:670–671

    Google Scholar 

  • Van Wyck Fleet J, Manberg PJ, Miller LL, Harto-Truax N, Sato T, Fleck RJ, Stern WC, Cato AE (1983) Overview of clinically significant adverse reactions to bupropion. J Clin Psychiatry 44:191–196

    Google Scholar 

  • Vogel JR (1975) Antidepressants and mouse-killing (muricide) behavior. In: Fielding S, Lal H (eds) Antidepressants. Futura, New York, pp 99–112

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Seiden, L.S., Dahms, J.L. & Shaughnessy, R.A. Behavioral screen for antidepressants: The effects of drugs and electroconvulsive shock on performance under a differential-reinforcement-of-low-rate schedule. Psychopharmacology 86, 55–60 (1985). https://doi.org/10.1007/BF00431684

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00431684

Key words

Navigation